Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Jun 3 | DNLI | Denali Therapeutics Inc. | AGRANT | 6,408 | — | — | +60.3% | Open the original filing on SEC.gov |
| Nov 4, 2025 | DNLI | Denali Therapeutics Inc. | AGRANT◆ | 31,897 | — | — | — | Open the original filing on SEC.gov |
| Nov 4, 2025 | DNLI | Denali Therapeutics Inc. | AGRANT | 10,632 | — | — | — | Open the original filing on SEC.gov |
| Jun 26, 2025 | LXEO | Lexeo Therapeutics, Inc. | AGRANT◆ | 22,916 | — | — | — | Open the original filing on SEC.gov |
| May 13, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◆ | 22,346 | — | — | — | Open the original filing on SEC.gov |
| May 13, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER | 22,346 | $4.30 | $96.1K | — | Open the original filing on SEC.gov |